Resmed (RMD) Non-Current Debt (2011 - 2026)

Resmed's Non-Current Debt history runs 16 years deep, the most recent figure standing at $404.2 million for Q1 2026.

• Quarterly Non-Current Debt fell 39.05% year-over-year to $404.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $404.2 million (down 39.05% YoY) and the FY2025 annual result came in at $658.4 million, down 5.58% from the prior year.
• Non-Current Debt was $404.2 million for Q1 2026 at Resmed, roughly flat from $403.9 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $1.8 billion in Q4 2022 and bottomed at $403.9 million in Q4 2025.
• A 5-year average of $891.1 million and a median of $697.3 million in 2024 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt soared 168.08% — and 2024, when it sank 51.28%.
• Resmed's Non-Current Debt stood at $1.8 billion in 2022, then slumped by 32.05% to $1.2 billion in 2023, then sank by 45.52% to $662.9 million in 2024, then plunged by 39.06% to $403.9 million in 2025, then climbed by 0.06% to $404.2 million in 2026.
• Business Quant data shows RMD's Non-Current Debt at $404.2 million in Q1 2026, $403.9 million in Q4 2025, and $408.7 million in Q3 2025.